Inovio Pharmaceuticals, Inc. (NASDAQ:INO) declared that the DARPA has given $12.2 M for a cooperative research that will be hosted by investigators from the Perelman School of Medication at the University of Pennsylvania; MedImmune, the world biologics study and growth support of AstraZeneca and INO. The team will grow DNA-based monoclonal antibodies for handling of infected disease. DARPA is an organization of the United State Division of Defense that makes and holds new technologies significant for nationwide security. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) belongs to Healthcare sector. Its weekly performance is 0.27%. On last trading day company shares ended up $11.23. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) distance from 50-day simple moving average (SMA50) is 4.46%. Delta Air Lines, Inc. (NYSE:DAL) announced its plans to expand its customer Porsche service to three more airports by Nov 30, 2014. The expansion of the transfer service will enable high value clients of the carrier to be transferred in Porsche vehicles from gate-to-gate on the tarmac (read more: Delta (DAL) to Expand Porsche Service to 3 More Airports). Delta Air Lines, Inc. (NYSE:DAL) shares decreased -1.06% in last trading session and ended the day at $41.87. DAL Gross Margin is 46.40% and its return on assets is 18.90%. Delta Air Lines, Inc. (NYSE:DAL) quarterly performance is 17.58%. LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global online retail company that delivers products directly to consumers around the world, today announced that it will participate in the following upcoming conferences in October and November 2014: On October 30, 2014, LightInTheBox will participate in the Jefferies 4th Annual Asia Summit. The summit will be held at the Island Shangri-La Hotel inHong Kong. On November 4- 5, 2014, LightInTheBox will participate in the Citi China Investor Conference. The Conference will be held at the Grand Hyatt Hotel in Macau. On 05 November, LightInTheBox Holding Co., Ltd. (NYSE:LITB) shares decreased -0.44% and was closed at $6.75. LITB EPS growth in last 5 year was 29.00%. LightInTheBox Holding Co., Ltd. (NYSE:LITB) year to date (YTD) performance is -16.56%. Ellomay Capital Ltd. (NYSEMKT:ELLO), an emerging operator in the renewable energy and energy infrastructure sector, today reported its unaudited financial results for the six month period ended June 30, 2014. Revenues were approximately $7.5 million for the six months ended June 30, 2014. Operating expenses were approximately $1.5 million for the six months ended June 30, 2014. Depreciation expenses were approximately $2.6 million for the six months ended June 30, 2014. These results include the results of two photovoltaic plants in the Veneto Region, Italy acquired on June 26, 2013 (the "Veneto PV Plants"). Gross profit was approximately $2.8 million for the six months ended June 30, 2014 and included impairment charges of approximately $0.6 million due to the approval by the Italian parliament in August 2014 and the conversion into law of the Italian decree, issued by the Italian President in June 2014, providing for a decrease in the Feed-in-Tariff guaranteed to existing Italian photovoltaic plants. General and administrative expenses were approximately $2.3 million for the six months ended June 30, 2014 and included expenses in the amount of approximately $0.5 million, such as payment of bonuses to employees and expenses in connection with a pre-bid agreement executed with respect to a joint offer to acquire participating interests in two exploration and drilling licenses off-shore Israel, which were not incurred by the Company in the six month period ended June 30, 2013. Ellomay Capital Ltd. (NYSEMKT:ELLO) ended the last trading day at $9.60. Company weekly volatility is calculated as 2.50% and price to cash ratio as 2.39. Ellomay Capital Ltd. (NYSEMKT:ELLO) showed a weekly performance of 1.37%. Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the 2014 Stifel Healthcare Conference on Tuesday, November 18, 2014 in New York City. Boston Scientific Corporation (NYSE:BSX) shares increased 0.53% in last trading session and ended the day at $13.33. BSX Gross Margin is 70.10% and its return on assets is 1.70%. Boston Scientific Corporation (NYSE:BSX) quarterly performance is 8.73%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
